References
- Morris LE, Moore JC, Schwartz JB. Characterization and performance of a new direct compression excipient for chewable tablets: Xylitab®. Drug Dev Ind Pharm 1996;22:925–32
- European Pharmacopoeia 6th Edition. Strasbourg: Council of Europe; 2007:304–6
- Olsen MR, Lindhart K, Overgard JM, et al. Influence of composition and geometry on chewability of Egalet® ADPREM tablets. Available from: http://www.egalet.dk/multimedia/Chewability_poster_20090717.ppt [last accessed 6 Oct 2012]
- Ambros MC, Podczeck F, Podczeck H, Newton JM. The characterization of the mechanical strength of chewable tablets. Pharm Dev Technol 1998;3:509–15
- Available from: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Information/Applications/Pharma%20Market%20Measurement/MIDAS%20Slim%20Jim%20BrEv%200113_spread_final.pdf [last accessed 21 Aug 2013]
- Klimek J, Hellwig E, Ahrens G. Fluoride taken up by plaque, by the underlying enamel and by clean enamel from three fluoride compounds in vitro. Caries Res 1982;16:156–61
- Matzker J, Schreiber J. Synthetischer Speichel zur Therapie der Hyposalivation insbesondere bei der radiogenen Sialadenitis. Z Laryngol Rhinol Otol 1972;51:422–8
- European Pharmacopoeia 6th Edition. Strasbourg: Council of Europe; 2007:279
- European Pharmacopoeia 6th Edition. Strasbourg: Council of Europe; 2007:278–9
- European Pharmacopoeia 6th Edition. Strasbourg: Council of Europe; 2007:263–5
- Pocztaruk R de L, Frasca LC, Rivaldo EG, et al. Protocol for production of a chewable material for masticatory function tests (Optocal – Brazilian version). Bras Oral Res 2008;22:305–10
- Mangelhaes IB, Pereira L-J, Marques LS, Gameiro GH. The influence of malocclusion on masticatory performance. Angle Orthodentist 2010;80:981–7